Amarin Corp Plc (AMRN)

[sts66]

If the ITC/FDA do not block DS versions of Vascepa ...they are de facto accepting them

And FDA will have an untenable situation on their hands, especially after a successful R-IT....cannot have a DS chemically identical to an Rx drug on the market, would put FDA into a position it from which they could not possibly defend themselves.